As expected, LINC01088‐OE led to decreases in the intracellular concentrations of total iron (Fe), ferrous iron (Fe2+), lipid ROS, the GSSG to GSH ratio, and MDA in GBM cells after treatment with erastin (Figure 3F–J). This evidence concerns the gene LINC01088 and glioblastoma.